Melatonin treatment protects against spinal cord injury induced functional and biochemical changes in rat urinary bladder

Journal of Pineal Research

Volumn 52, Issue 3, 2012, Pages 340-348

  Erşahin, Mehmet ^a   Özdemir, Zarife ^b   Özsavci, Derya ^b   Akakin, Dilek ^b   Yeǧen, Berrak Ç ^b   Reiter, Russel J ^c   Şener, Göksel ^b  

^a Samsun Education and Research Hospital ^*  (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

bladder; caspase 3; nerve growth factor; oxidative stress; spinal cord injury

Indexed keywords

CARBACHOL; CASPASE 3; CHLORPROMAZINE; DRUG VEHICLE; GLUTATHIONE; KETAMINE; MALONALDEHYDE; MELATONIN; NERVE GROWTH FACTOR; NEURON SPECIFIC ENOLASE; PROTEIN S100B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER DYSFUNCTION; BLOOD SAMPLING; CHEMICAL ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; HISTOLOGY; MUSCLE ISOMETRIC CONTRACTION; NEUROLOGIC EXAMINATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; SPINAL CORD INJURY; WISTAR ALBINO GLAXO RAT;

ANIMALS; CASPASE 3; GLUTATHIONE; MALONDIALDEHYDE; MELATONIN; RATS; RATS, WISTAR; SPINAL CORD INJURIES; URINARY BLADDER;

EID: 84858754265     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2011.00948.x     Document Type: Article

References (58)

1. Azbill RD, Mu X, Bruce-Keller AJ, et al., Impaired mitochondrial function, oxidative stress and altered antioxidant enzyme activities following traumatic spinal cord injury. Brain Res 1997; 765: 283-290. (Pubitemid 27397624)
2. Herrera JJ, Haywood-Watson RJ 2nd, Grill RJ,. Acute and chronic deficits in the urinary bladder after spinal contusion injury in the adult rat. J Neurotrauma 2010; 27: 423-431.
3. Toosi KK, Nagatomi J, Chancellor MB, et al., The effects of long-term spinal cord injury on mechanical properties of the rat urinary bladder. Ann Biomed Eng 2008; 36: 1470-1480.
4. Braughler JM, Hall ED,. Central nervous system trauma and stroke I. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radic Biol Med 1989; 6: 289-301. (Pubitemid 19076495)
5. Reiter RJ, Tan DX, Manchester LC, et al., Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys 2001; 34: 237-256. (Pubitemid 33615836)
6. Hall ED, Braughler JM, Mccall JM,. New pharmacological treatment of acute spinal cord trauma. J Neurotrauma 1988; 5: 81-89.
7. Tan DX, Chen LD, Poeggeler B, et al., Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993; 1: 57-60.
8. Bonnefont-Rousselot D, Collin F, Jore D, et al., Reaction mechanism of melatonin oxidation by reactive oxygen species in vitro. J Pineal Res 2011; 50: 328-335.
9. Galano A, Tan DX, Reiter RJ,. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011; 51: 1-16.
10. Reiter RJ, Tan DX, Osuna C, et al., Actions of melatonin in the reduction of oxidative stress: a review. J Biomed Sci 2000; 7: 444-458.
11. Reiter RJ, Tan DX, Leon J, et al., When melatonin gets on your nerves: its beneficial actions in experimental models of stroke. Exp Biol Med (Maywood) 2005; 230: 104-117.
12. Reiter RJ, Tan DX, Manchester LC, et al., Melatonin defeats neurally-derived free radicals and reduces the associated neuromorphological and neurobehavioral damage. J Physiol Pharmacol 2007; 58 (Suppl 6): 5-22.
13. Beni SM, Kohen R, Reiter RJ, et al., Melatonin-induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late-phase activation of NF-kappaB and AP-1. FASEB J 2004; 18: 149-151.
14. Ozdemir D, Uysal N, Gonenc S, et al., Effect of melatonin on brain oxidative damage induced by traumatic brain injury in immature rats. Physiol Res 2005; 54: 631-637. (Pubitemid 43161729)
15. Samantaray S, Sribnick EA, Das A, et al., Melatonin attenuates calpain upregulation, axonal damage and neuronal death in spinal cord injury in rats. J Pineal Res 2008; 44: 348-357. (Pubitemid 351545738)
16. Hong Y, Palaksha KJ, Park K, et al., Melatonin plus exercise-based neurorehabilitative therapy for spinal cord injury. J Pineal Res 2010; 49: 201-209.
17. Tsai MC, Chen WJ, Tsai MS, et al., Melatonin attenuates brain contusion-induced oxidative insult, inactivation of signal transducers and activators of transcription 1, and upregulation of suppressor of cytokine signaling-3 in rats. J Pineal Res 2011; 51: 233-245.
18. Chen HY, Chen TY, Lee MY, et al., Melatonin decreases neurovascular oxidative/nitrosative damage and protects against early increases in the blood-brain barrier permeability after transient focal cerebral ischemia in mice. J Pineal Res 2006; 41: 175-182.
19. Tai SH, Hung YC, Lee EJ, et al., Melatonin protects against transient focal cerebral ischemia in both reproductively active and estrogen-deficient female rats: the impact of circulating estrogen on its hormetic dose-response. J Pineal Res 2011; 50: 292-303.
20. Lapi D, Vagnani S, Cardaci E, et al., Rat pial microvascular responses to melatonin during bilateral common carotid artery occlusion and reperfusion. J Pineal Res 2011; 51: 136-144.
21. Ayer RE, Sugawara T, Chen W, et al., Melatonin decreases mortality following severe subarachnoid hemorrhage. J Pineal Res 2008; 44: 197-204. (Pubitemid 351252923)
22. Erşahin M, Toklu HZ, Cetinel S, Yüksel M, Yeǧen BC, ŞEner G,. Melatonin reduces experimental subarachnoid hemorrhage-induced oxidative brain damage and neurological symptoms. J Pineal Res 2009; 46: 324-332.
23. Allen AR,. Surgery of experimental lesion of spinal cord equivalent to crush injury of fracture dislocation of spinal column. A preliminary report. JAMA 1911; 57: 878-880.
24. Gale K, Kerasidis H, Wrathall JR,. Spinal cord contusion in the rat: behavioral analysis of functional neurologic impairment. Exp Neurol 1985; 88: 123-134. (Pubitemid 15114489)
25. ŞEner G, Sehirli AO, Paskaloglu K, et al., Melatonin treatment protects against ischemia/reperfusion-induced functional and biochemical changes in rat urinary bladder. J Pineal Res 2003; 34: 226-230. (Pubitemid 36356850)
26. Beuge JA, Aust SD,. Microsomal lipid peroxidation. Meth Enzymol 1978; 53: 302-311.
27. Beutler E, Duron O, Kelly BM,. Improved method for the determination of blood glutathione. J Lab Clin Med 1963; 61: 882-888.
28. Persson L, Hårdemark H, Edner G, Ronne E, Mendel-Hartvig I, Påhlman S,. S-100 protein in cerebrospinal fluid of patients with subarachnoid haemorrhage: a potential marker of brain damage. Acta Neurochir (Wien) 1988; 93: 116-122.
29. Ma J, Novikov LN, Karlsson K, et al., Plexus avulsion and spinal cord injury increase the serum concentration of S-100 protein: an experimental study in rats. Scand J Plast Reconstr Surg Hand Surg 2001; 35: 355-359. (Pubitemid 34025229)
30. Esposito E, Mazzon E, Paterniti I, et al., Olprinone attenuates the acute inflammatory response and apoptosis after spinal cord trauma in mice. PLoS ONE 2010; 5: e12170.
31. Bao F, Chen Y, Dekaban GA, et al., Early anti-inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats. J Neurochem 2004; 88: 1335-1344. (Pubitemid 38366908)
32. Dasari VR, Spomar DG, Cady C, et al., Mesenchymal stem cells from rat bone marrow downregulate caspase-3-mediated apoptotic pathway after spinal cord injury in rats. Neurochem Res 2007; 32: 2080-2093. (Pubitemid 350059852)
33. Kruman I, Bruce-Keller AJ, Bredesen D, et al., Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J Neurosci 1997; 17: 5089-5100. (Pubitemid 27263822)
34. Erten SF, Kocak A, Ozdemir I, et al., Protective effect of melatonin on experimental spinal cord ischemia. Spinal Cord 2003; 41: 533-538. (Pubitemid 37260326)
35. Genovese T, Mazzon E, Muia C, et al., Attenuation in the evolution of experimental spinal cord trauma by treatment with melatonin. J Pineal Res 2005; 38: 198-208. (Pubitemid 40396179)
36. Paradies G, Petrosillo G, Paradies V, et al., Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res 2010; 48: 297-310.
37. Ballatori N, Krance SM, Notenboom S, et al., Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem 2009; 390: 191-214.
38. Erşahin M, Sehirli O, Toklu HZ, et al., Melatonin improves cardiovascular function and ameliorates renal, cardiac and cerebral damage in rats with renovascular hypertension. J Pineal Res 2009; 47: 97-106.
39. Sener G, Atasoy BM, Ersoy Y, et al., Melatonin protects against ionizing radiation-induced oxidative damage in corpus cavernosum and urinary bladder in rats. J Pineal Res 2004; 37: 241-246. (Pubitemid 39461953)
40. Reiter RJ, Paredes SD, Manchester LC, et al., Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol 2009; 44: 175-200.
41. Reiter RJ, Fuentes-Broto L, Paredes SD, et al., Melatonin and the pathophysiology of cellular membranes. Marmara Pharm J 2010; 14: 1-9.
42. Allegra M, Reiter RJ, Tan DX, et al., The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003; 34: 1-10. (Pubitemid 36140351)
43. Cuzzocrea S, Reiter RJ,. Pharmacological actions of melatonin in acute and chronic inflammation. Curr Top Med Chem 2002; 2: 153-165.
44. Shaafi S, Afrooz MR, Hajipour B, et al., Anti-oxidative effect of lipoic acid in spinal cord ischemia/reperfusion. Med Princ Pract 2011; 20: 19-22.
45. Hakan T, Toklu HZ, Biber N, et al., Meloxicam exerts neuroprotection on spinal cord trauma in rats. Int J Neurosci 2011; 121: 142-148.
46. Toklu HZ, Hakan T, Celik H, et al., Neuroprotective effects of alpha-lipoic acid in experimental spinal cord injury in rats. J Spinal Cord Med 2010; 33: 401-409.
47. Saganová K, Orendácová J, Sulla I, et al., Effects of long-term FK506 administration on functional and histopathological outcome after spinal cord injury in adult rat. Cell Mol Neurobiol 2009; 29: 1045-1051.
48. Nath M, Wheeler JS Jr, Walter JS,. Urologic aspects of traumatic central cord syndrome. J Am Paraplegia Soc 1993; 16: 160-164.
49. De Groat WC, Yoshimura N,. Changes in afferent activity after spinal cord injury. Neurourol Urodyn 2010; 29: 63-76.
50. Urso ML, Chen YW, Scrimgeour AG, et al., Alterations in mRNA expression and protein products following spinal cord injury in humans. J Physiol 2007; 579: 877-892. (Pubitemid 46404366)
51. Paskaloglu K, ŞEner G, Kapucu C, et al., Melatonin treatment protects against sepsis-induced functional and biochemical changes in rat ileum and urinary bladder. Life Sci 2004; 74: 1093-1104. (Pubitemid 37547946)
52. Barde YA,. The nerve growth factor family. Prog Growth Factor Res 1990; 2: 237-248.
53. Ochodnický P, Cruz CD, Yoshimura N, et al., Nerve growth factor in bladder dysfunction: contributing factor, biomarker, and therapeutic target. Neurourol Urodyn 2011; 30: 1227-1241.
54. Abe T, Morgan DA, Gutterman DD,. Protective role of nerve growth factor against postischemic dysfunction of sympathetic coronary innervation. Circulation 1997; 95: 213-220. (Pubitemid 27029965)
55. Aloe L, Levi-Montalcini R,. Nerve growth factor induced overgrowth of axotomized superior cervical ganglia in neonatal rats. Similarities and differences with NGF effects in chemically axotomized sympathetic ganglia. Arch Ital Biol 1979; 117: 287-307. (Pubitemid 10143463)
56. Apfel SC, Arezzo JC, Lipson L, et al., Nerve growth factor prevents experimental cisplatin neuropathy. Ann Neurol 1992; 31: 76-80.
57. Vizzard MA,. Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction. Exp Neurol 2000; 161: 273-284. (Pubitemid 30136549)
58. Pongsa-Asawapaiboon A, Asavaritikrai P, Withyachumnarnkul B, et al., Melatonin increases nerve growth factor in mouse submandibular gland. J Pineal Res 1998; 24: 73-77. (Pubitemid 28168317)